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Summary
Mucosa associated lymphoid tissue (MALT)
lymphomas are low-grade, non-Hodgkin’s B cell
lymphomas, mainly occurring in the gastroin-
testinal tract, but also in other tissues. We
describe the management of a patient with
hypothyroidism, tracheoesophageal compressive
symptoms and chest tightness affected by a
thyroid MALT lymphoma. The patient under-
went debulking thyroidectomy and temporary
tracheostomy in order to reduce dysphonia and
dysphagia, followed by adjuvant chemotherapy
and subsequently radiation therapy. A CT scan
performed at the end of radiotherapy 6 months
after surgery revealed remnants of residual tissue
from the thyroidectomy without any pathological
findings. Eur. J. Oncol., 17 (2), 93-98, 2012
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Riassunto
I linfomi MALT sono dei linfomi non-Hodgkin a
cellule B a basso grado che in genere insorgono a
livello del tratto gastrointestinale, ma anche in
altri tessuti. Descriviamo in questo articolo il
management clinico-chirurgico di un paziente
con ipotiroidismo, sintomi da compressione
tracheo-esofagea e senso di oppressione toracica,
affetto da linfomaMALT della tiroide. Il paziente
è stato sottoposto a parziale asportazione della
massa tiroidea e tracheostomia allo scopo di
ridurre i sintomi compressivi ed in seguito a trat-
tamento chemioterapico e radioterapico. L’esame
TC effettuato una volta conclusa la radioterapia,
circa 6 mesi dopo l’intervento, ha evidenziato gli
esiti della tiroidectomia parziale in assenza di
altri reperti patologici. Eur. J. Oncol., 17 (2), 93-
98, 2012
Parole chiave: tiroide, linfoma, MALT
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Introduction
Isaacson and Wright described the existence of
mucosa associated lymphoid tissue (MALT
lymphoma) for the first time in 1983 from a small
subgroup of patients with gastrointestinal B-cell
lymphoma (1). It was classified as “extranodal
marginal zone B cell lymphoma” in the REAL
(1994) classification and recently in the 4th edition
(2008) of WHO classification of lymphomas (2, 3).
MALT lymphomas are low-grade, non-Hodgkin’s B
cell lymphomas, mainly occurring in the gastroin-
testinal tract, but also in other tissues such as sali-
vary glands, skin, liver, thyroid, prostate and ocular
conjunctiva and adnexa (4). They generally follow
an indolent course; however in one third of the cases
malignancies have already spread to other mucosal
locations, bone marrow or lymph nodes at the time
of diagnosis (5). We report in the present article a
case of thyroid MALT lymphoma in a patient with
hypofunctioning thyroid goiter and describe the clin-
ical and surgical management adopted.
Case Report
A 60-year-old male was admitted to our institution
in November 2010 with a 3-month history of wors-
ening tracheoesophageal compressive symptoms
(dysphonia and dysphagia for solid foods) and chest
tightness. The patient was diagnosed with chronic
hypothyroidism in 1998 and he was under levothy-
roxine therapy. Physical examination revealed hali-
tosis, thick neck with increased thyroid size with a
uniformly hard consistency and fixed during swal-
lowing but without pain at palpation. Cornage and
tirage were present. Furthermore, laterocervical
lymph nodes were palpable and swollen bilaterally.
Laboratory tests which included the thyroid func-
tional status due to levothyroxine treatment were
within the normal range.
Neck ultrasound demonstrated an enlarged left
lobe of the thyroid measured as 99 x 44 x 66 mm,
characterized by the presence of heterogeneous
tissue surrounding a nodular lesion without micro-
calcifications or a pattern compatible with a malig-
nant nature. No pathological findings were detected
in the right lobe.
Cervical and mediastinum computed tomography
(CT) scans showed a large goiter that extended from
the left lobe to the mediastinum, displacing vascular
structures to the left. The trachea and the esophagus
were surrounded by thyroid tissue and displaced to
the right (fig. 1). The tracheal lumen was reduced
and multiple swollen lymph nodes of as much as 1
cm in diameter were found bilaterally in the latero-
cervical, supraclavicular, mediastinal and axillary
areas. The patient underwent a bronchoscopy that
confirmed a transverse reduction of the tracheal
lumen in the upper third of the organ due to external
compression. Transbronchial needle aspiration
(TBNA) cytology was inconclusive.
Because of the worsening of compressive symp-
toms the patient was referred for total thyroidectomy
and a temporary tracheostomy. During the operation
the thyroid appeared to be grayish-white in color and
presented a bulky, hard consistency, which made it
impossible to perform a total thyroidectomy with
respect to the neighboring tracheal, esophageal,
vascular, and nervous structures.
We performed a partial debulking of the thyroid
located anteriorly to the trachea, and the frozen
section examination of the specimen demonstrated
the presence of a small-cell lymphomatous lesion.
Final histological diagnosis was MALT lymphoma
of the thyroid gland. Immunohistochemistry was
positive for CD20, CD45, CD79a, CD43, BLC2,
BLC6, and BLC10 and was negative for CD5, CD10,
CD45R0, Cyclin-1, LMP1, TDT, CAM5.2, TTF1,
TGB, and calcitonin. Immunoreaction was strongly
positive for CD20 (fig. 2), focally positive for BCL6
(fig. 3), and exclusively cytoplasmatic for BCL10.
The post-operative course was uneventful, the
compressive symptoms were reduced and the patient
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Fig. 1. CT scan: CT showing the lesion before surgery
08-pulighe:08-pulighe  16-10-2012  8:17  Pagina 94
was referred to the hematology department where he
began chemotherapy treatment. Regimens included
4 cycles of combined rituximab, cyclophosphamide,
doxorubicin, prednisone and vincrisitine. At the end
of chemotherapy, approximately 3 months after
surgery, a CT scan was performed and documented
the reduction of the neoplastic mass. Radiotherapy
treatment was subsequently employed with 18
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Fig. 2. Diffuse immunohisto-
chemical positivity for CD 20
Fig. 3. Focal immunohisto-
chemical positivity for BCL 6
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cycles for a total amount of 36 Gray. A new CT scan
after radiotherapy (6 months after surgery) revealed
remnants of residual tissue from the thyroidectomy
without any pathological findings.
Discussion
Primitive thyroid lymphomas are rare. Their
annual incidence amounts to 2.1 cases out of 1
million, representing approximately 1-5% of the
overall thyroid malignancies and 2-4% of the overall
extranodal lymphomas (6-10). The prevalence is
higher in females (male/female ratio 1:3/4), and a
peak incidence occurs at around 60 years of age (11,
12). They are classically classified as either non-
Hodgkin’s Lymphomas (NHL), with a B-cell and a
T-cell variant, or Hodgkin’s Lymphomas (HL). The
diffuse large B-cell lymphoma is the most common
type representing about 50-70% of the overall
thyroid lymphomas, while other subtypes are rarer:
follicular lymphoma (12%), HL (7%) and Burkitt’s
lymphoma (4%) (5, 11). MALT appears as a further
variant, with proper clinical and pathological
features, which represents the 6-27% of thyroid
lymphoma overall (13). It was originally identified
as a pseudo-lymphoma because of its characteristic
to remain confined to the tissue of origin, but it is
now appreciated that it is a clonal B-cell neoplasm
that may locally recur, metastasize or be transformed
into a high-grade B-cell lymphoma. MALT
lymphomas generally occur in middle to older aged
individuals, particularly females (male/female ratio
1:2-4) (8).
The pathophysiological mechanisms of MALT
lymphomas’ genesis are not yet clear. The most
accredited hypothesis is that MALT lymphomas
arise in the context of persistent antigen stimulation
for chronic disease or autoimmunity, which causes
subsequent neoplastic transformation of antigen-
dependent B-cells due to unknown mutations. The
tumor is not initially able to spread beyond the
chronically inflamed tissue, but with addiction of
further mutations evolves into antigen-independent
and capable of systemic spread neoplasia (8).
This hypothesis has emerged from studies on
gastric lymphomas in patients with Helicobacter
Pylori infection and of salivary gland lymphomas in
patients affected by Sjögren syndrome. Thyroid
MALT lymphomas are also frequently associated
with long-term Hashimoto thyroiditis. Fortunately,
despite the high frequency of chronic thyroiditis
(anti-thyroid autoantibodies found in 15% of the
general population), their incidence is relatively
very low. The latency time after the onset of
autoimmune thyroiditis is calculated to be about 20
to 30 years (8). Further investigations are necessary
to comprehend the pathophysiology that causes the
disease to progress from chronic inflammation to
neoplasia.
The clinical presentation of thyroid MALT
lymphomas is extremely variable. Patients may
appear completely asymptomatic, particularly those
previously affected by chronic thyroiditis. Others
may present with a rapidly growing painless thyroid
mass that causes compressive symptoms like hoarse-
ness, dysphagia and dyspnea. This clinical picture
was evident in our patient at the time of initial eval-
uation.
The use of fine needle aspiration biopsy (FNAB)
in the diagnosis of thyroid MALT lymphomas is
controversial (14). Our patient did not undergo
FNAB, as worsening compressive symptoms led to
an urgent surgical operation. Sangalli et al. reported
10 thyroid MALT lymphomas studied with FNAB;
correct diagnoses were obtained in only four cases.
Similarly, in a retrospective review of 23 primary
thyroid lymphomas, Cha et al. demonstrated that the
results of FNAB for such diagnosis were often
inconsistent, even when employing immunohisto-
chemistry. However, many studies achieved good
results using a combination of FNAB and flow
cytometry (14).
The most employed imaging methods for the diag-
nosis of lymphomas include ultrasonography (US),
iodine and tecnezium scintigraphy, CT and nuclear
magnetic resonance (NMR), but these techniques
have a minor role in the diagnosis of MALT
lymphomas (15, 16). Nonetheless, CT is crucial in
staging and predicting the prognosis. In our experi-
ence we employed US and CT which revealed IIE-
stage disease, according to the Ann Arbor classifica-
tion revised by Mussoff. The cervical lymph nodes
are most frequently involved at the time of diag-
nosis, while further lymph node involvement repre-
sents a negative prognostic factor (17).
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The optimal treatment and appropriate follow-up
program of primary thyroid lymphomas remain
controversial. The selection of the best treatment
strategy is based on the histologic subtype and on the
extent of the disease. The principal therapeutic
methods available include surgery, chemotherapy
and radiotherapy.
Concerning the use of such methods as single
treatments, several authors report encouraging
outcomes. Thieblemont studied seven patients with
stage IE thyroid MALT lymphoma treated with
surgery alone and reported that 100% experienced
local control of the disease, utilizing adjuvant radio-
therapy in cases of incomplete surgical resection (5).
In a retrospective review Tsang et al reported excel-
lent local disease control in 13 patients with MALT
lymphoma (stage I-IIE) treated with 30-35 Gy of
radiotherapy (13). For thyroid MALT lymphomas in
stage IE or IIE the regimen of cyclophosphamide,
doxorubicin, vincristine, and prednisone has been
proposed as a combination chemotherapy treatment
in cases of lymph nodal involvement (18). Other
chemotherapy associations proposed include
fludarabine and mitoxantrone or cyclophosphamide,
vincristine and prednisone (19).
Several multimodal approaches have been also
described. Malek et al have suggested that the choice
of the treatment strategy depends on the size of the
neoplasia. The authors propose a multimodal
approach that begins with early thyroidectomy
followed by chemotherapy or radiotherapy, indi-
cating radiotherapy for thyroid MALT lymphomas
larger than 7 cm (20).
Generally patients with local thyroid MALT
lymphoma have an excellent prognosis after
thyroidectomy, radiotherapy or chemotherapy, even
with a single treatment. Many studies report a 5-year
survival rate higher than 90% (21, 22). In rare cases
the prognosis may be worse because of the higher
aggressiveness and the early onset of compression
on neighboring mediastinal structures, which
occurred in our patient. In these circumstances the
role of surgery seems limited to controlling the
compressive symptoms and it must be followed with
adjuvant treatments. The most promising adjuvant
therapy seems to be a combination of cyclophos-
phamide, doxorubicin, vincristine and prednisone,
which was the treatment offered to our patient (18).
Conclusions
MALT lymphomas of the thyroid gland are rare
and generally not aggressive neoplasms. In rare
cases the clinical presentation may consist in early
tracheoesophageal compression symptoms. Such
presentation imposes a decompressive surgical
approach which furthermore allows to obtain the
exact diagnosis since preoperative FNAB shows a
low specificity. The surgical treatment must be
followed by adjuvant chemotherapy and radio-
therapy in order to guarantee the best oncologic
outcomes.
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